Development and testing of therapeutics to treat COVID-19

A £10 million fund to support research to accelerate the development and testing of therapeutics that can be rapidly deployed to treat the symptoms of COVID-19. UK-based medical research charity LifeArc is seeking applications from academics or companies with therapeutics that could be repurposed or repositioned for use in COVID-19 patients.

Amount
£10M
Agency or Funder
LifeArc
Eligibility (if available)

Academics, NHS employees or companies that have therapeutics that could be repurposed or repositioned for use in COVID-19 patients

Foreign participation? (where known)
Yes
Keywords
Treatment
Clinical Studies
Country
UK
Link(s) to announcement or call
https://www.lifearc.org/funding/covid-19-funding/
Date of announcement
Date application deadline
View more opportunities from UK View more opportunities